Holen Sie sich die Stockscreener-App
32.17
1.26%
0.40
Handel nachbörslich:
32.17
Schlusskurs vom Vortag:
$31.77
Offen:
$32.68
24-Stunden-Volumen:
985.25K
Relative Volume:
1.08
Marktkapitalisierung:
$2.82B
Einnahmen:
$214.83M
Nettoeinkommen (Verlust:
$-160.74M
KGV:
-17.34
EPS:
-1.8553
Netto-Cashflow:
$-105.39M
1W Leistung:
-0.06%
1M Leistung:
-11.40%
6M Leistung:
+36.14%
1J Leistung:
+34.27%
1-Tages-Spanne:
$31.86
$33.00
1-Wochen-Bereich:
$31.54
$34.66
52-Wochen-Spanne:
$13.45
$39.28
Ideaya Biosciences Inc Stock (IDYA) Company Profile
Firmenname
Ideaya Biosciences Inc
Sektor
Branche
Telefon
650-443-6209
Adresse
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare IDYA vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDYA
Ideaya Biosciences Inc
|
32.17 | 2.79B | 214.83M | -160.74M | -105.39M | -1.8553 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.92 | 116.41B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
785.51 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
811.45 | 50.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.16 | 43.76B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
353.92 | 38.40B | 4.98B | 69.60M | 525.67M | 0.5198 |
Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-07 | Fortgesetzt | UBS | Buy |
| 2025-11-24 | Eingeleitet | Truist | Buy |
| 2025-09-18 | Eingeleitet | Guggenheim | Buy |
| 2025-09-04 | Eingeleitet | Barclays | Overweight |
| 2025-09-04 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-07-22 | Eingeleitet | TD Cowen | Buy |
| 2025-07-10 | Fortgesetzt | Goldman | Neutral |
| 2025-06-26 | Eingeleitet | Wells Fargo | Overweight |
| 2024-11-18 | Eingeleitet | Stephens | Overweight |
| 2024-11-05 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-08 | Eingeleitet | Mizuho | Outperform |
| 2024-03-08 | Eingeleitet | BTIG Research | Buy |
| 2023-08-08 | Eingeleitet | SVB Securities | Outperform |
| 2023-05-24 | Eingeleitet | Goldman | Buy |
| 2023-04-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-23 | Eingeleitet | Berenberg | Buy |
| 2023-02-28 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-12-28 | Eingeleitet | CapitalOne | Overweight |
| 2022-10-27 | Eingeleitet | Citigroup | Buy |
| 2022-08-15 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2022-03-10 | Hochstufung | Stifel | Hold → Buy |
| 2021-09-23 | Eingeleitet | Stifel | Hold |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-03-11 | Eingeleitet | Guggenheim | Buy |
| 2020-10-07 | Eingeleitet | Wedbush | Outperform |
| 2020-09-01 | Eingeleitet | Northland Capital | Outperform |
| 2020-07-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-06-17 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-03-13 | Eingeleitet | ROTH Capital | Buy |
| 2019-10-17 | Eingeleitet | Oppenheimer | Outperform |
| 2019-09-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-06-17 | Eingeleitet | Citigroup | Buy |
| 2019-06-17 | Eingeleitet | JP Morgan | Neutral |
| 2019-06-17 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Ideaya Biosciences Inc Aktie (IDYA) Neueste Nachrichten
IDEAYA Biosciences (IDYA): Unpacking The 46.63% Potential Upside In Precision Oncology - DirectorsTalk Interviews
IDEAYA Biosciences, Inc. $IDYA Shares Acquired by New York State Common Retirement Fund - MarketBeat
Liquidity Mapping Around (IDYA) Price Events - Stock Traders Daily
IDEAYA Biosciences to Participate in Upcoming February 2026 Investor Relations Events - MEXC
Has The Market Overreacted To Recent Weakness In IDEAYA Biosciences (IDYA) Shares? - Yahoo Finance
AlphaQuest LLC Has $1.12 Million Stock Position in IDEAYA Biosciences, Inc. $IDYA - MarketBeat
Institution Moves: Is IDEAYA Biosciences Inc benefiting from innovation trends2025 Support & Resistance & Safe Capital Investment Plans - baoquankhu1.vn
A Look At IDEAYA Biosciences (IDYA) Valuation After Recent Share Price Pullback - Yahoo Finance
Knights of Columbus Asset Advisors LLC Invests $934,000 in IDEAYA Biosciences, Inc. $IDYA - MarketBeat
IDEAYA Biosciences to Participate in Upcoming February 2026 Investor Relations Events | IDYA Stock News - Longbridge
IDEAYA Grants 44,200 Stock Options to New Employee - intellectia.ai
Ideaya Biosciences announces inducement grants under Nasdaq listing rule 5635(c)(4) - marketscreener.com
New IDEAYA hire receives 44,200 stock options in Nasdaq inducement grant - stocktitan.net
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - TradingView
Forecast Cut: Will IDEAYA Biosciences Inc benefit from geopolitical trendsWatch List & Consistent Income Trade Recommendations - baoquankhu1.vn
What are IDEAYA Biosciences Inc.’s recent SEC filings showingIPO Watch & Daily Profit Maximizing Trade Tips - mfd.ru
IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Potential 44.88% Upside Fuels Investor Interest - DirectorsTalk Interviews
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Weekly Trades: What chart patterns are forming on IDEAYA Biosciences IncMarket Weekly Review & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Why (IDYA) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Street Watch: What is IDEAYA Biosciences Inc. s P E ratio telling usQuarterly Risk Review & Short-Term Swing Trade Alerts - baoquankhu1.vn
Sectors Review: Whats the beta of IDEAYA Biosciences Inc stockJuly 2025 News Drivers & AI Powered Trade Plan Recommendations - baoquankhu1.vn
RBC Raises Price Target on IDEAYA Biosciences to $45 From $41, Keeps Outperform, Speculative Risk - marketscreener.com
Winners Losers: Is IDEAYA Biosciences Inc subject to activist investor interestQuarterly Market Summary & AI Driven Stock Reports - baoquankhu1.vn
Ideaya Biosciences advances with IDE892 study targeting MTAP-deleted tumors - MSN
IDEAYA Biosciences, Inc. $IDYA Stake Lifted by SG Americas Securities LLC - MarketBeat
FEDERATED HERMES, INC. Reduces Stake in IDEAYA Biosciences Inc - GuruFocus
IDEAYA Biosciences (IDYA) Stock Analysis: A Biotech Gem With A Potential 34.92% Upside - DirectorsTalk Interviews
Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (MDLN) and IDEAYA Biosciences (IDYA) - The Globe and Mail
Understanding Momentum Shifts in (IDYA) - Stock Traders Daily
IDEAYA Biosciences Outlines 2026 Corporate Objectives and Clinical Progress - intellectia.ai
IDEAYA Biosciences Updates 2026 Corporate Objectives at J.P. Morgan Conference - Intellectia AI
New cancer trials aim to save vision and extend lives in rare eye cancer - Stock Titan
IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference - Sahm
IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference | IDYA Stock News - Longbridge
IDEAYA Biosciences Updates 2026 Strategic Objectives, Plans to Advance Four Registrational Trials - Intellectia AI
Why IDEAYA Biosciences Inc. stock attracts global investors2025 Market Overview & Safe Capital Growth Stock Tips - ulpravda.ru
How buybacks impact IDEAYA Biosciences Inc. stock valueWeekly Risk Summary & Fast Gain Stock Trading Tips - Улправда
Why IDEAYA Biosciences Inc. stock is considered a top pickFit and Size Notes & walk-ready comfort choices - Улправда
GSK ends collaboration with IDEAYA for two candidates - MSN
Earnings Recap: How analysts rate IDEAYA Biosciences Inc. stock todayTake Profit & Safe Capital Growth Tips - Улправда
Why IDEAYA Biosciences Inc. stock remains on buy listsJuly 2025 Short Interest & Smart Money Movement Tracker - Улправда
What downside risks could hit IDEAYA Biosciences Inc. (30J) stockQuarterly Portfolio Review & Verified Entry Point Detection - Улправда
Ideaya Biosciences stock hits 52-week high at 37.09 USD By Investing.com - Investing.com Nigeria
IDEAYA Biosciences (NASDAQ:IDYA) Sets New 12-Month HighStill a Buy? - MarketBeat
IDEAYA Biosciences (NASDAQ:IDYA) Coverage Initiated at UBS Group - MarketBeat
Ideaya Biosciences stock hits 52-week high at 37.09 USD - Investing.com
Ideaya Biosciences stock gets Buy rating from UBS with $50 price target - Investing.com Canada
Will IDEAYA Biosciences Inc. stock rally after Fed decisions2026 world cup usa national team group stage star players high defensive line odds analysis guide - Улправда
Will IDEAYA Biosciences Inc. stock outperform growth indexes2026 world cup usa national team third place match goalkeepers possession football group prediction preview - ulpravda.ru
Truist Securities raises Ideaya Biosciences stock price target to $60 By Investing.com - Investing.com Canada
Finanzdaten der Ideaya Biosciences Inc-Aktie (IDYA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
1.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):